The nocebo effect and patient perceptions of biosimilars in inflammatory bowel disease

被引：6
作者：
Pineles, David [1 ]
Malter, Lisa [2 ]
Liang, Peter S. [3 ]
Arsuaga, Amy [4 ]
Bosworth, Brian [1 ,4 ]
Hudesman, David P. [4 ]
Chang, Shannon [4 ]
机构：
[1] NYU Langone Hlth, Dept Med, New York, NY USA
[2] Bellevue Hosp, Div Gastroenterol, New York, NY USA
[3] Manhattan Med Ctr, VA New York Harbor Healthcare Syst, Div Gastroenterol, New York, NY USA
[4] NYU Langone Hlth, Div Gastroenterol, Inflammatory Bowel Dis Ctr, New York, NY 10016 USA
来源：
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 2018年 / 74卷 / 10期
关键词：
D O I：
10.1007/s00228-018-2492-7
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：1361 / 1362
页数：2
相关论文
共 50 条
[31]   Biosimilars in Inflammatory Bowel Disease: Facts and Fears of Extrapolation [J].
Ben-Horin, Shomron ;
Vande Casteele, Niels ;
Schreiber, Stefan ;
Lakatos, Peter Laszlo .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2016, 14 (12) :1685-1696
[32]   Biosimilars in Inflammatory Bowel Disease - Accumulating Clinical Evidence [J].
McConachie, Sean ;
Wilhelm, Sheila M. ;
Kale-Pradhan, Pramodini B. .
EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2017, 10 (04) :391-400
[33]   The Sincerest Form of Flattery? Biosimilars in Inflammatory Bowel Disease [J].
Patil, Seema A. ;
Bhat, Shubha ;
Limdi, Jimmy K. ;
Farraye, Francis A. ;
Cross, Raymond K. .
INFLAMMATORY BOWEL DISEASES, 2022, 28 (12) :1915-1923
[34]   Biosimilars of Adalimumab in Inflammatory Bowel Disease: Are we Ready for that? [J].
Argollo, Marjorie ;
Fiorino, Gionata ;
Gilardi, Daniela ;
Furfaro, Federica ;
Roda, Giulia ;
Loy, Laura ;
Allocca, Mariangela ;
Peyrin-Biroulet, Laurent ;
Danese, Silvio .
CURRENT PHARMACEUTICAL DESIGN, 2019, 25 (01) :7-12
[35]   Biosimilars in inflammatory bowel disease: ready for prime time? [J].
Gomollon, Fernando .
CURRENT OPINION IN GASTROENTEROLOGY, 2015, 31 (04) :290-295
[36]   The Economic Impact of the Introduction of Biosimilars in Inflammatory Bowel Disease [J].
Severs, M. ;
Oldenburg, B. ;
van Bodegraven, A. A. ;
Siersema, P. D. ;
Mangen, M-J. J. .
JOURNAL OF CROHNS & COLITIS, 2017, 11 (03) :289-296
[37]   Position statement on the use of biosimilars in inflammatory bowel disease [J].
Emanuel, Burri ;
Pascal, Juillerat ;
Michel, Maillard H. ;
Michael, Manz ;
Pierre, Michetti ;
Christian, Mottet ;
Gerhard, Rogler ;
Nadine, Zahnd ;
Stephan, Vavricka .
SWISS MEDICAL WEEKLY, 2019, 149
[38]   Insights on the use of biosimilars in the treatment of inflammatory bowel disease [J].
Zheng, Michael K. ;
Shih, David Q. ;
Chen, Gary C. .
WORLD JOURNAL OF GASTROENTEROLOGY, 2017, 23 (11) :1932-1943
[39]   Challenges of modern day transition care in inflammatory bowel disease: From inflammatory bowel disease to biosimilars [J].
Ali Hakizimana ;
Iftikhar Ahmed ;
Rachel Russell ;
Mark Wright ;
Nadeem A Afzal .
World Journal of Gastroenterology, 2017, (25) :4473-4479
[40]   Challenges of modern day transition care in inflammatory bowel disease: From inflammatory bowel disease to biosimilars [J].
Hakizimana, Ali ;
Ahmed, Iftikhar ;
Russell, Rachel ;
Wright, Mark ;
Afzal, Nadeem A. .
WORLD JOURNAL OF GASTROENTEROLOGY, 2017, 23 (25) :4473-4479
12345